Bevacizumab improves splenomegaly and decreases production of hyaluronic acid after L-OHP based chemotherapy.
Arakawa Y, Shimada M, Utsunomiya T, Imura S, Morine Y, Ikemoto T, Hanaoka J, Kanamoto M, Iwahashi S, Saito Y, Yamada S, Asanoma M, Takasu C, Bando Y.
Arakawa Y, et al. Among authors: morine y.
Anticancer Res. 2014 Apr;34(4):1953-8.
Anticancer Res. 2014.
PMID: 24692731